These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34353323)

  • 61. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
    [TBL] [Abstract][Full Text] [Related]  

  • 62. (Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada.
    Olding M; Boyd J; Kerr T; Fowler A; McNeil R
    Int J Drug Policy; 2023 Jan; 111():103929. PubMed ID: 36529032
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 64. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effectiveness of drug-related Good Samaritan laws: A review of the literature.
    Moallef S; Hayashi K
    Int J Drug Policy; 2021 Apr; 90():102773. PubMed ID: 32467017
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Illicit drug use while admitted to hospital: Patient and health care provider perspectives.
    Strike C; Robinson S; Guta A; Tan DH; O'Leary B; Cooper C; Upshur R; Chan Carusone S
    PLoS One; 2020; 15(3):e0229713. PubMed ID: 32134973
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
    Stowe MJ; Calvey T; Scheibein F; Arya S; Saad NA; Shirasaka T; Dannatt L; Ghosh A; Yee A; Ratta-Apha W; Vadivel R; Siste K; Shah B; Ramalho R; Narasimha VL; Delic M; Peyron E; Onoria JLG; Pant SB; Boujraf S; Grandinetti P; Morgan N
    J Addict Med; 2020 Dec; 14(6):e287-e289. PubMed ID: 33009167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis.
    Walters SM; Bolinski RS; Almirol E; Grundy S; Fletcher S; Schneider J; Friedman SR; Ouellet LJ; Ompad DC; Jenkins W; Pho MT
    Addict Sci Clin Pract; 2022 Apr; 17(1):24. PubMed ID: 35468860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.
    Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
    Harm Reduct J; 2022 Jul; 19(1):72. PubMed ID: 35780109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Overdose Crisis and Using Alone: Perspectives of People Who Use Drugs in Rural and Semi-Urban Areas of British Columbia.
    Fernando S; Hawkins J; Kniseley M; Sikora M; Robson J; Snyder D; Battle C; Salmon A
    Subst Use Misuse; 2022; 57(12):1864-1872. PubMed ID: 36096482
    [No Abstract]   [Full Text] [Related]  

  • 71. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
    Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
    Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Virtual Overdose Response for People Who Use Opioids Alone: Protocol for a Feasibility and Clinical Trial Study.
    Bristowe SK; Ghosh SM; Trew M; ; Rittenbach K
    JMIR Res Protoc; 2021 May; 10(5):e20183. PubMed ID: 33978598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of the COVID-19 pandemic on access to supervised consumption programs.
    Gubskaya E; Kennedy MC; Hayashi K; Cui Z; Milloy MJ; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):16. PubMed ID: 36899417
    [TBL] [Abstract][Full Text] [Related]  

  • 74. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
    Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
    SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.
    Carroll JJ; Mackin S; Schmidt C; McKenzie M; Green TC
    Harm Reduct J; 2022 Feb; 19(1):9. PubMed ID: 35120531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Practices of care among people who buy, use, and sell drugs in community settings.
    Kolla G; Strike C
    Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.
    Ali F; Russell C; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    Int J Drug Policy; 2021 Jul; 93():103237. PubMed ID: 33893026
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acceptability of technological solutions for overdose monitoring: Perspectives of people who use drugs.
    Tsang VWL; Papamihali K; Crabtree A; Buxton JA
    Subst Abus; 2021; 42(3):284-293. PubMed ID: 31657675
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Women who use drugs: engagement in practices of harm reduction care.
    Austin T; Lavalley J; Parusel S; Collins AB; Olding M; Boyd J
    Harm Reduct J; 2023 Apr; 20(1):49. PubMed ID: 37055805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.